JPRN-UMIN000029435已完成2 期
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung cancer - A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung cancer
Department of respiratory medicine, Kurashiki Central Hospital0 个研究点目标入组 20 人开始时间: 2017年10月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of severe hypersensitivity to taxane group 2. History of severe hypersensitivity to Carboplatin 3. History of severe hypersensitivity to albumin preparation 4. Interstitial lung disease or pulmonary fibrosis 5. Severe infectious disease or severe uncontrolled complication 6. Active malignancy of other organ 7. HBs antigen positive
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
招募中
不适用
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
招募中
2 期
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66
招募中
2 期
JESS14Ewing sarcoma family tumorC04.557.450.565.575.650.800Ewing sarcomaJPRN-jRCTs021180022Sano Hideki66
进行中（未招募）
2 期
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30